Skip to main content
. Author manuscript; available in PMC: 2021 Mar 17.
Published in final edited form as: Clin Cancer Res. 2020 Jun 25;26(18):4970–4982. doi: 10.1158/1078-0432.CCR-19-3890

Table 1C:

Univariable analysis of overall Survival by Patient Characteristics

Patient Characteristic Measurement Overall Survival
Deaths/N 5-Year (SD) P-Value
All Patients 195/380 66.7% (2.5%)
HAF Mean* 0.02
<0.14 133/229 61.0% (3.3%)
>=0.14 59/146 75.3% (3.6%)
HIF-2α Mean* <0.001
<0.102 60/117 60.5% (4.7%)
0.102-<0.307 69/120 57.8% (4.6%)
>=0.307 51/119 79.6% (3.7%)
HIF-1α (total) Mean* 0.02
<0.0171 57/124 71.8% (4.1%)
0.0171-<0.041 63/122 66.0% (4.4%)
>=0.041 70/124 61.1% (4.4%)
HIF-1α (Stroma) Mean* 0.02
<0.005 55/116 74.4% (4.1%)
0.005-<0.014 65/135 66.6% (4.1%)
>=0.014 71/120 57.8% (4.6%)
*

These variables are continuous measures. The p-value is based on the continuous variable, and the groupings are used for presentation of time estimates only.